Healthcare · Healthcare Software
OpenEvidence
Miami, USA · Series D
Implied valuation
Probability modeled from funding stage, momentum & liquidity signals.
Valuation Trajectory
Funding-round staircase from founding · log scale. Modeled round ladder anchored to the current valuation — illustrative, not a published figure.
IPO Model Drivers
Why the odds read this way
Factor weights are illustrative decompositions of the modeled IPO probability, not guarantees.
Down-Round Risk
Valuation downside pressure
Mixed signals — limited valuation history with 69% modeled IPO odds keep down-round risk in the middle band.
Asset brief
OpenEvidence is a Healthcare · Healthcare Software company last marked at $12B. Stage: Series D, $225MM raised to date. No verified market-moving events in the last 30 days.
OpenEvidence is an AI copilot for doctors that helps them make high-stakes decisions at the point of care. It is the most widely used medical AI among verified U.S. physicians and has supported over 100 million AI-powered clinical consultations.
Capital Timeline
Funding & liquidity milestones
Series D
$225MM raised · $12B